Live Breaking News & Updates on Translational Molecular

Stay updated with breaking news from Translational molecular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nanoparticles for optimized cancer therapy

Nanoparticles for optimized cancer therapy
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Myrto Ischyropoulou , Claus Feldmann , Frauke Alves , Joanna Napp , Research Group , Multidisciplinary Sciences , Max Planck Institute , University Medical Center , Karlsruhe Institute Of Technology , Karlsruhe Institute , Translational Molecular ,

KIT - KIT - Media - Press Releases - PI 2023 - Nanoparticles for optimized cancer therapy

KIT - KIT - Media - Press Releases - PI 2023 - Nanoparticles for optimized cancer therapy
kit.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kit.edu Daily Mail and Mail on Sunday newspapers.

Baden Wüberg , Myrto Ischyropoulou , Joanna Napp , Claus Feldmann , Frauke Alves , Research Group , Max Planck Institute , Multidisciplinary Sciences , University Medical Center , Karlsruhe Institute Of Technology , Karlsruhe Institute , Translational Molecular ,

TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for Oncology

TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for Oncology
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Vivek Subbiah , Michael Dudley , Zdravka Medarova , Sendurai Mani , Translational Molecular , Associate Professor , Investigational Cancer Therapeutics ,

Single-cell map offers a new immunotherapy target for lung cancer treatment


Single-cell map offers a new immunotherapy target for lung cancer treatment
Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind spatial atlas of early-stage lung cancer and surrounding normal lung tissue at single-cell resolution, providing a valuable resource for studying tumor development and identifying new therapeutic targets. The study was published today in
Cancer Discovery, a journal of the American Association for Cancer Research.
The findings reveal a heterogeneous lung cancer ecosystem, with extensive interactions between cancer cells and the surrounding microenvironment that regulate early cancer development. By studying the crosstalk between the tumor and surrounding immune cells, researchers identified and validated CD24, an immune checkpoint protein, as a new immunotherapy target for lung cancer treatment. ....

United States , Guangchun Han , Linghua Wang , Ansam Sinjab , Emily Henderson , American Association For Cancer Research , University Of Texas Md Anderson Cancer Center , Study Co , Cancer Center , Cancer Discovery , American Association , Study Co Senior Author , Associate Professor , Translational Molecular , Translational Molecular Pathology , ஒன்றுபட்டது மாநிலங்களில் , எமிலி ஹென்டர்சன் , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் , படிப்பு இணை , புற்றுநோய் மையம் , புற்றுநோய் கண்டுபிடிப்பு , அமெரிக்கன் சங்கம் , படிப்பு இணை மூத்தவர் நூலாசிரியர் , இணை ப்ரொஃபெஸர் , மொழிபெயர்ப்பு மூலக்கூறு ,